Company / Current Assets
Oric Pharmaceuticals, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$288.5M
FY2025
5-year range
$210.5M / $288.5M
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#168 of 213
Health Care
What the data says
Oric Pharmaceuticals, Inc.'s current assets of $288M is lower than 79% of companies in the Health Care sector (FY2025). Current Assets has increased for 3 consecutive years, from $210M in FY2022 to $288M in FY2025.
Based on SEC 10-K filings.
$288M in FY2025 with a 5-year CAGR of -0.6%.
Improved from $213M to $288M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 213This company $288.5M Sector average $2.5B
▼
-88.6% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2025, current assets increased 10.0% year-over-year.
- Ranks #168 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $288.5M | +10.0% |
| FY2024 | $262.3M | +23.4% |
| FY2023 | $212.6M | +1.0% |
| FY2022 | $210.5M | -12.5% |
| FY2021 | $240.5M | -18.9% |
| FY2020 | $296.7M | +229.7% |
| FY2019 | $90.0M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026